159 related articles for article (PubMed ID: 30921587)
1. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
[TBL] [Abstract][Full Text] [Related]
4. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
[TBL] [Abstract][Full Text] [Related]
5. Activation of autophagy reverses progressive and deleterious protein aggregation in PRPF31 patient-induced pluripotent stem cell-derived retinal pigment epithelium cells.
Georgiou M; Yang C; Atkinson R; Pan KT; Buskin A; Molina MM; Collin J; Al-Aama J; Goertler F; Ludwig SEJ; Davey T; Lührmann R; Nagaraja-Grellscheid S; Johnson CA; Ali R; Armstrong L; Korolchuk V; Urlaub H; Mozaffari-Jovin S; Lako M
Clin Transl Med; 2022 Mar; 12(3):e759. PubMed ID: 35297555
[TBL] [Abstract][Full Text] [Related]
6. Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa.
Buskin A; Zhu L; Chichagova V; Basu B; Mozaffari-Jovin S; Dolan D; Droop A; Collin J; Bronstein R; Mehrotra S; Farkas M; Hilgen G; White K; Pan KT; Treumann A; Hallam D; Bialas K; Chung G; Mellough C; Ding Y; Krasnogor N; Przyborski S; Zwolinski S; Al-Aama J; Alharthi S; Xu Y; Wheway G; Szymanska K; McKibbin M; Inglehearn CF; Elliott DJ; Lindsay S; Ali RR; Steel DH; Armstrong L; Sernagor E; Urlaub H; Pierce E; Lührmann R; Grellscheid SN; Johnson CA; Lako M
Nat Commun; 2018 Oct; 9(1):4234. PubMed ID: 30315276
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation.
Terray A; Fort V; Slembrouck A; Nanteau C; Sahel JA; Reichman S; Audo I; Goureau O
Stem Cell Res; 2017 Dec; 25():26-29. PubMed ID: 29040912
[TBL] [Abstract][Full Text] [Related]
9. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
Li YP; Liu H; Jin ZB
Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
[TBL] [Abstract][Full Text] [Related]
10. Study of gene-targeted mouse models of splicing factor gene Prpf31 implicated in human autosomal dominant retinitis pigmentosa (RP).
Bujakowska K; Maubaret C; Chakarova CF; Tanimoto N; Beck SC; Fahl E; Humphries MM; Kenna PF; Makarov E; Makarova O; Paquet-Durand F; Ekström PA; van Veen T; Leveillard T; Humphries P; Seeliger MW; Bhattacharya SS
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5927-33. PubMed ID: 19578015
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa.
Waseem NH; Vaclavik V; Webster A; Jenkins SA; Bird AC; Bhattacharya SS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1330-4. PubMed ID: 17325180
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
13. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
[TBL] [Abstract][Full Text] [Related]
14. Course of Ocular Function in PRPF31 Retinitis Pigmentosa.
Hafler BP; Comander J; Weigel DiFranco C; Place EM; Pierce EA
Semin Ophthalmol; 2016; 31(1-2):49-52. PubMed ID: 26959129
[TBL] [Abstract][Full Text] [Related]
15. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
[TBL] [Abstract][Full Text] [Related]
16. Gene of the month:
Rose AM; Luo R; Radia UK; Bhattacharya SS
J Clin Pathol; 2017 Sep; 70(9):729-732. PubMed ID: 28663330
[TBL] [Abstract][Full Text] [Related]
17. Targeted Next Generation Sequencing Revealed Novel PRPF31 Mutations in Autosomal Dominant Retinitis Pigmentosa.
Xie D; Peng K; Yi Q; Liu W; Yang Y; Sun K; Zhu X; Lu F
Genet Test Mol Biomarkers; 2018 Jul; 22(7):425-432. PubMed ID: 29957067
[TBL] [Abstract][Full Text] [Related]
18. Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene.
Zhou Y; Ding C; Xia S; Jing Y; Mao S; Liu J; Chen J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 Apr; 44():101742. PubMed ID: 32244200
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31 in Spanish families with autosomal dominant retinitis pigmentosa.
Martínez-Gimeno M; Gamundi MJ; Hernan I; Maseras M; Millá E; Ayuso C; García-Sandoval B; Beneyto M; Vilela C; Baiget M; Antiñolo G; Carballo M
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2171-7. PubMed ID: 12714658
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
